EMRİ, K. A. S. Et Al. 2016. Diagnostic Utility of Mesothelin Osteopontin and MegakaryocytePotentiation Factor in Turkish Patients with Malignant Mesothelioma. WCLC 201617th World Conference on Lung Cancer , 350.

EMRİ, K. A. S., DİKMEN, Z. G., SARINÇ ULAŞLI, S., esendağlı, d., yılmaz, u., ŞİMŞEK ÖZEK, N., ... SEVERCAN, F.(2016). Diagnostic Utility of Mesothelin Osteopontin and MegakaryocytePotentiation Factor in Turkish Patients with Malignant Mesothelioma . WCLC 201617th World Conference on Lung Cancer (pp.350).

EMRİ, KAHRAMAN Et Al. "Diagnostic Utility of Mesothelin Osteopontin and MegakaryocytePotentiation Factor in Turkish Patients with Malignant Mesothelioma," WCLC 201617th World Conference on Lung Cancer, 2016

EMRİ, KAHRAMAN A. Et Al. "Diagnostic Utility of Mesothelin Osteopontin and MegakaryocytePotentiation Factor in Turkish Patients with Malignant Mesothelioma." WCLC 201617th World Conference on Lung Cancer , pp.350, 2016

EMRİ, K. A. S. Et Al. (2016) . "Diagnostic Utility of Mesothelin Osteopontin and MegakaryocytePotentiation Factor in Turkish Patients with Malignant Mesothelioma." WCLC 201617th World Conference on Lung Cancer , p.350.

@conferencepaper{conferencepaper, author={KAHRAMAN AHMET SALİH EMRİ Et Al. }, title={Diagnostic Utility of Mesothelin Osteopontin and MegakaryocytePotentiation Factor in Turkish Patients with Malignant Mesothelioma}, congress name={WCLC 201617th World Conference on Lung Cancer}, city={}, country={}, year={2016}, pages={350} }